Maximum Daily Dose of Oral Acyclovir for Herpes in Children Over 2 Years
For children over 2 years of age with herpes infections, the maximum daily dose of oral acyclovir is 3,200 mg/day (80 mg/kg/day), administered as 800 mg four times daily or 20 mg/kg per dose four times daily, whichever is lower.
Dosing Framework by Indication
The maximum daily dose varies based on the specific herpes infection being treated:
For Varicella (Chickenpox)
- Dose: 20 mg/kg per dose orally 4 times daily (80 mg/kg/day) for 5 days 1
- Maximum: Children over 40 kg should receive the adult dose of 800 mg 4 times daily (3,200 mg/day) 1
- Timing: Treatment should be initiated within 24 hours of rash onset for optimal efficacy 1
For Herpes Simplex Virus (HSV) Infections
Mild symptomatic gingivostomatitis or genital herpes:
- Dose: 20 mg/kg per dose (maximum 400 mg/dose) orally 3 times daily for 5-14 days 2
- Maximum daily dose: 1,200 mg/day for children <45 kg
Moderate to severe symptomatic gingivostomatitis:
- Initial IV therapy at 5-10 mg/kg per dose 3 times daily, then transition to oral acyclovir 2
- Continue oral therapy until lesions completely heal
For Herpes Zoster (Shingles)
- Dose: 20 mg/kg per dose (maximum 800 mg/dose) orally 4 times daily for 7-10 days 2
- Maximum daily dose: 3,200 mg/day
- Timing: Most effective when started within 48-72 hours of rash onset 2
Important Clinical Considerations
Renal Function Adjustments
Dose reduction is mandatory in renal impairment 1. For children with:
- Normal renal function (CrCl >10 mL/min/1.73m²): Standard dosing applies
- Renal impairment (CrCl 0-10 mL/min/1.73m²): Reduce frequency to every 12 hours for most indications 1
- Augmented renal clearance (eGFR >250 mL/min/1.73m²): May require higher doses (15-20 mg/kg every 6 hours IV) to achieve therapeutic levels 3
Weight-Based Dosing Caveat
The evidence consistently shows that children weighing over 40-45 kg should receive adult dosing rather than weight-based pediatric dosing 2, 1. This prevents excessive doses in larger children while ensuring adequate exposure.
Bioavailability Limitations
Oral acyclovir has poor and dose-dependent bioavailability (10-20%), which decreases further with increasing doses 1. This explains why:
- The 800 mg dose given 4 times daily (for varicella/zoster) represents the practical maximum
- Higher individual doses do not proportionally increase plasma concentrations
- Some children may require therapeutic drug monitoring if clinical response is inadequate 3
Common Pitfalls to Avoid
- Do not exceed 3,200 mg/day total regardless of weight, as bioavailability decreases and toxicity risk increases
- Do not use adult dosing in children under 40 kg - always calculate weight-based doses with the specified maximums per dose
- Do not forget renal dose adjustments - elderly patients and those with renal impairment are at higher risk for CNS toxicity 1
- Do not delay treatment - efficacy is significantly reduced when therapy is initiated >24 hours after symptom onset for varicella or >72 hours for zoster 1
Alternative Considerations
While valacyclovir and famciclovir have superior pharmacokinetics in adults, no pediatric preparations exist and dosing data in children are limited 2. These agents could be considered in postpubertal adolescents able to receive adult dosing, but acyclovir remains the standard of care for younger children based on established safety and efficacy data 2, 4.